Literature DB >> 1663298

Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.

J Korula1, A Yellin, G Kanel, G Campofiori, P Nichols.   

Abstract

Entities:  

Keywords:  Americas; Biology; California; Case Studies; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Developed Countries; Diseases; Endometrial Effects; Endometrium; Family Planning; Genitalia; Genitalia, Female; Hepatic Effects; Histology; Liver Neoplasms--etiology; Menstruation Disorders; Methodological Studies; Neoplasms; Norethindrone Acetate--side effects; Norethindrone--side effects; North America; Northern America; Oral Contraceptives--side effects; Physiology; Research Methodology; Studies; Surgery; Treatment; Ultrasonics; United States; Urogenital System; Uterus

Mesh：

Substances：

Year:  1991        PMID： 1663298      PMCID： PMC1003033     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  10 in total

Review 1.  Hepatic tumors: possible relationship to use of oral contraceptives.

Authors:  G Klatskin
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

2.  Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.

Authors:  E J Gyorffy; J E Bredfeldt; W C Black
Journal:  Ann Intern Med       Date:  1989-03-15       Impact factor: 25.391

3.  Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.

Authors:  S C Gordon; K R Reddy; A S Livingstone; L J Jeffers; E R Schiff
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

4.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

Authors:  F L Johnson; K G Lerner; M Siegel; J R Feagler; P W Majerus; J R Hartmann; E D Thomas
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

5.  Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.

Authors:  M Davis; B Portmann; M Searle; R Wright; R Williams
Journal:  Br Med J       Date:  1975-11-29

6.  Liver-cell adenomas associated with use of oral contraceptives.

Authors:  H A Edmondson; B Henderson; B Benton
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

7.  Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.

Authors:  J B Rooks; H W Ory; K G Ishak; L T Strauss; J R Greenspan; A P Hill; C W Tyler
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

Review 8.  Hepatic tumors induced by sex steroids.

Authors:  E T Mays; W Christopherson
Journal:  Semin Liver Dis       Date:  1984-05       Impact factor: 6.115

9.  Regression of liver cell adenomas associated with oral contraceptives.

Authors:  H A Edmondson; T B Reynolds; B Henderson; B Benton
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

10.  Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids.

Authors:  Z D Goodman; K G Ishak
Journal:  Hepatology       Date:  1982 Jul-Aug       Impact factor: 17.425
  10 in total
  9 in total

Review 1.  Non-viral causes of hepatocellular carcinoma.

Authors:  Wojciech Blonski; David S Kotlyar; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

2.  Non-viral factors contributing to hepatocellular carcinoma.

Authors:  Manal A Hamed; Sanaa A Ali
Journal:  World J Hepatol       Date:  2013-06-27

Review 3.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.

Authors:  Jan H M B Stoot; Robert J S Coelen; Mechteld C De Jong; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

4.  Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.

Authors:  Sanjay Kakar; James P Grenert; Valerie Paradis; Nicolas Pote; Shriram Jakate; Linda D Ferrell
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

5.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 6.  New advances in hepatocellular carcinoma.

Authors:  Sonia Pascual; Iván Herrera; Javier Irurzun
Journal:  World J Hepatol       Date:  2016-03-28

Review 7.  [Hepatocellular carcinoma in the non-cirrhotic liver].

Authors:  M Evert; F Dombrowski
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

8.  Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers.

Authors:  Song-Lin An; Li-Ming Wang; Wei-Qi Rong; Fan Wu; Wei Sun; Wei-Bo Yu; Li Feng; Fa-Qiang Liu; Fei Tian; Jian-Xiong Wu
Journal:  Chin J Cancer       Date:  2015-05-24

Review 9.  Molecular pathogenesis of hepatic adenomas and its implications for surgical management.

Authors:  Siong-Seng Liau; M Saeed Qureshi; Raaj Praseedom; Emmanuel Huguet
Journal:  J Gastrointest Surg       Date:  2013-07-09       Impact factor: 3.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.